Portal de Periódicos da CAPES

Compliance With Pharmacotherapy in Mood Disorders

1995; Slack Incorporated (United States); Volume: 25; Issue: 5 Linguagem: Inglês

10.3928/0048-5713-19950501-03

1938-2456

Monica Ramirez Basco, A. John Rush,

Mental Health Treatment and Access

ASCP SPEAKS OUTCompliance With Pharmacotherapy in Mood Disorders Monica Ramirez Basco, PhD, , and , PhD A John Rush, MD, , MD Monica Ramirez Basco, PhD and A John Rush, MD Published OnlineMay 01, 1995https://doi.org/10.3928/0048-5713-19950501-03Cited by:35PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Robins LN, Heizer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984; 41:949-958, Google Scholar2. Zis AP, Goodwin FK. Major affective disorders as a recurrent illness: a critical review. Arch Gen Psychiatry. 1979; 36:835-839. Google Scholar3. Goodwin FK, Jamison KR. Manie-Depressive Illness. New York: Oxford University Press; 1990. Google Scholar4. Angst J. Clinical indications for a prophylactic treatment of depression. Adv Biol Psychiatry. 1981; 7:218-229. Google Scholar5. Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand. 1985; 71(suppl 317):1-34. Google Scholar6. Zis AP, Grof P, Webster M, Goodwin FK Prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 1980;16:47-49. Google Scholar7. Weissman MM, Myers J. Affective disorders in a US urban community. The use of research diagnostic criteria in an epidemiological survey. Arch Gen Psychiatry. 1978; 35:1304-1311. Google Scholar8. Keller MB, Shapiro RW, Lavori RW, Wolfe N. Relapse in major depressive disorder: analysis with the life table. Arch Gen Psychiatry. 1982; 39:911-915. Google Scholar9. Consensus Development Panel. NIMH/NIH consensus development conference statement on mood disorders: pharmacological prevention of reoccurrence. Am J Psychiatry. 1985; 142:469-476. Google Scholar10. Robins E, Guze S. Classification of affective disorders: the primary-secondary, the endogenous-reactive, and the neurotic-psychotic concepts. In: Williams TA, Katz MM, Shielf JA Jr, eds. Recent Advances in the Psychology of the Depressive Illnesses. Proceedings of a Workshop sponsored by the NIMH. Washington, DC: US Government Printing Office; 1972. Google Scholar11. Murphy G, Woodruff JR, Herjanic M, et al. Variability of the clinical course of primary affective disorder. Arch Gen Psychiatry. 1974; 35:757-762. Google Scholar12. Kroll LP, Habenichet M, Chan S, et al. Medication compliance, antidepressant blood levels and side effects in southeast Asian patients. J Clin Psychopharmacol 1990; 10(4):279-283. Google Scholar13. Kucera-Bozarth K, Beck NC, Lyss L. Compliance with lithium regimens. J Psychosoc Nurs Ment Health Serv. 1982; 20:11-15. Google Scholar14. Kurata K, Kido H, Hasegawa M, Inoue M, Yamaguchi N. A comparison of maprotiline and its desmethylated metabolite serum concentrations in outpatients and inpatients. Jpn J Psychiatry Neurol. 1987; 41:255-260. Google Scholar15. Park LC, Lipman RS. A comparison of patient dosage deviation reports with pill counts. Psychopharmacologia. 1964; 6:299-302. Google Scholar16. Hollister LE. Plasma concentrations of tricyclic antidepressants in clinical practice. J Clin Psychiatry. 1982; 43:66-69. Google Scholar17. Holinger PC, Wolpert EA. A 10 year follow-up of lithium use. Illinois MedicalJournal. 1979; 156(2):99-104. Google Scholar18. Connelly CE, Davenport YB, Nurnberger JI. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry. 1982; 39:585-588. Google Scholar19. Fawcett J, Kravitz HM. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. J Clin Psychiatry. 1985; 46:58-60. Google Scholar20. Danion JM, Neureuther C, Krieger-Finance F, Imbs JL, Singer L. Compliance with long-term lithium treatment in major affective disorders. Pharmacopsychiatry. 1987; 20:230-231. Google Scholar21. Strober M, Morrell W, Lampert C, Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry. 1990; 147(4):457-461. Google Scholar22. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991; 48:1082-1088. Google Scholar23. Connelly CE. Compliance with outpatient lithium therapy. Perspectives in Psychiatric Care. 1984; 22:44-50. Google Scholar24. Schwarcz G, Silbergeld S. Serum lithium spot checks to evaluate medication compliance. J Clin Psychopharmacol 1983; 3:356-358. Google Scholar25. Placidi G, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind trial of 83 patients. J Clin Psychiatry. 1986; 47:490-494. Google Scholar26. Luznat RM, Murphy DP, Nunn CMH. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry. 1988; 153:198-204. Google Scholar27. Jacob M, Turner L, Kupfer DJ, Jarrett DB, Buzzinotti E, Bernstein P. Attrition in maintenance therapy for recurrent depression. J Affect Disord. 1984; 6:181-189. Google Scholar28. Overall JE, Donachie ND, Faillace LA. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus Imipramine. J Clin Psychiatry. 1987; 48:51-54. Google Scholar29. Pugh R. An association between hostility and poor adherence to treatment in patients suffering from depression. Br J Med Psychol 1983; 56:205-208. Google Scholar30. Johnson DAW. Depression: treatment compliance in general practice. Acta Psychiatr Scand. 1981; 290(suppl):447-453. Google Scholar31. Persons JB, Burns DD, Perloff JM. Predictors of dropout and outcome in cognitive therapy for depression in a private practice setting. Cognitive Therapy and Research. 1988; 12:557-575. Google Scholar32. Rabin AS, Kaslow NJ, Rehm LP. Factors influencing continuation in behavioral therapy. Behav Bes Ther. 1985; 23:695-698. Google Scholar33. Kornblith SJ, Rehm L, O'Hara MW, Lamparski DM. The contribution of self-reinforcement training and behavioral assignments to the efficacy of self-control therapy for depression. Cognitive Therapy and Research. 1983; 7:499-528. Google Scholar34. Eddy DM, Hassleblad V, Shachter R. A Baysian method for synthesizing evidence: a confidence profile method. J Tech Assess Health Care. 1990; 6:31-35. Google Scholar35. Aagaard J, Vestergaard P, Maarbjerg K Adherence to lithium prophylaxis, II: multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry. 1988; 21:166-170. Google Scholar36. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord. 1990; 18:259-266. Google Scholar37. Frank E. Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharmacol Bull. 1985; 21:37-42. Google Scholar38. Last CG, Thase ME, Hersen M, Bellack AS, Himmelhoch KM. Patterns of attrition for psychosocial and pharmacologic treatments of depression. J Clin Psychiatry. 1985; 46:361-366. Google Scholar39. Simons AD, Levine JL, Lustman PJ, Murphy GE. Patient attrition in a comparative outcome study of depression: a follow-up report. J Affect Disord. 1984; 6:163-173. Google Scholar40. Lenzi A, Lazzerini G, Placidi F, Cassano GB, Akiskal HS. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychia. 1989; 22:34-37. Google Scholar41. Gitlin MJ, Cochran SD, Jamison KR. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry. 1989; 50:127-131. Google Scholar42. Johnson DAW. Treatment of depression in general practice. British Medical Journal. 1973; 2:18-20. Google Scholar43. Nilson A, Axelsson R. Factors associated with discontinuation of long-term lithium treatment. Acta Psychiatr Scand. 1989; 80:221-230. Google Scholar44. McLean PD, Hakstian AR. Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol. 1979; 47:818-836. Google Scholar45. Vestergaard P, Amdisen A. Patient attitudes toward lithium. Acta Psychiatr Scand. 1983; 67:8-12. Google Scholar46. Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium. Arch Gen Psychiatry. 1979; 36:866-869. Google Scholar47. Davenport YB, Ebert MH, Adland ML, Goodwin FK Couples group therapy as an adjunct to lithium maintenance of the manic patient. Am J Orthopsychiatry. 1977; 47(3):495-502. Google Scholar48. Powell BJ, Othmer E, Sinkhorn C. Pharmacological aftercare for homogeneous groups of patients. Hosp Community Psychiatry. 1977; 28:125-127. Google Scholar49. Shakir SA, Volkmar FR, Bacon S, et al. Group psychotherapy as an adjunct to lithium maintenance. Am J Psychiatry. 1979; 136:455-456. Google Scholar50. Wulsin L, Bachop M, Hoffman D. Group therapy in manic-depressive illness. Am JPsychother. 1988; 2:263-271. Google Scholar51. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders, J Consult Clin Psychol. 1984; 52:873-878. Google Scholar52. VanGent EM, Zwart FM. Psychoeducation of partners of bipolar manic patients. J Affect Disord. 1991; 21:15-18. Google Scholar53. Altamura AC, Mauri M. Plasma concentration, information and therapy adherence during long-term treatment with antidepressants. Br J Clin Pharmacol. 1985; 20:714-716. Google Scholar54. Youssel FA. Compliance with therapeutic regimens: a follow-up study for patients with affective disorders. J AdvNurs. 1983;8:513-517. Google Scholar55. Seltzer A, Roncari I, Garfinkel P. Effect of patient education on medication compliance. Can J Psychiatry. 1980; 25:638-645. Google Scholar56. Myers ED, Calvert EJ. Information, compliance and side effects: a study of patients on antidepressant medication. Br J Clin Pharmacol. 1984; 17:21-25. Google Scholar Next article FiguresReferencesRelatedDetailsCited by Basco M and Celis-de Hoyos C (2012) Biopsychosocial Model of Hypersexuality in Adolescent Girls With Bipolar Disorder: Strategies for Intervention, Journal of Child and Adolescent Psychiatric Nursing, 10.1111/j.1744-6171.2011.00312.x, 25:1, (42-50), Online publication date: 1-Feb-2012. Bowers R, Weston C and Jackson J (2012) Child and Adolescent Affective Disorders and their Treatment Clinical Child Psychiatry, 10.1002/9781119962229.ch12, (189-214), Online publication date: 30-Mar-2012. Lazarou C, Kouta C, Kapsou M and Kaite C (2011) Overview of depression: epidemiology and implications for community nursing practice, British Journal of Community Nursing, 10.12968/bjcn.2011.16.1.41, 16:1, (41-47), Online publication date: 1-Jan-2011. Yoshimura R, Umene-Nakano W, Ueda N, Ikenouchi-Sugita A, Hori H, Katsuki A, Hayashi K, Miyamoto K, Kodama Y and Nakamura J (2010) No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.1136, 25:6, (487-490) Arean P and Ayalon L (2010) Major Depression Handbook of Clinical Psychology Competencies, 10.1007/978-0-387-09757-2_23, (637-670), . Kronmüller K, Saha R, Kratz B, Karr M, Hunt A, Mundt C and Backenstrass M (2007) Reliability and Validity of the Knowledge about Depression and Mania Inventory, Psychopathology, 10.1159/000111550, 41:2, (69-76), . Johnson S and Fulford D (2008) Development of the treatment attitudes questionnaire in bipolar disorder, Journal of Clinical Psychology, 10.1002/jclp.20465, 64:4, (466-481), Online publication date: 1-Apr-2008. Goethe J, Woolley S, Cardoni A, Woznicki B and Piez D (2007) Selective Serotonin Reuptake Inhibitor Discontinuation, Journal of Clinical Psychopharmacology, 10.1097/jcp.0b013e31815152a5, 27:5, (451-458), Online publication date: 1-Oct-2007. Rafanelli C, Fava G and Sonino N (2007) Sequential treatment of depression in primary care, International Journal of Clinical Practice, 10.1111/j.1742-1241.2007.01342.x, 61:10, (1719-1729) Conus P, Berk M and McGorry P (2016) Pharmacological Treatment in the Early Phase of Bipolar Disorders: What Stage are we at?, Australian & New Zealand Journal of Psychiatry, 10.1080/j.1440-1614.2006.01775.x, 40:3, (199-207), Online publication date: 1-Mar-2006. Harvey B, Retief R, Korff A and Wegener G (2006) Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: Role of 5HT 2A/C -receptors, Metabolic Brain Disease, 10.1007/s11011-006-9018-1, 21:2-3, (201-210), Online publication date: 21-Oct-2006. COFFMAN S, DIMIDJIAN S and BAER R (2006) MINDFULNESS-BASED COGNITIVE THERAPY FOR PREVENTION OF DEPRESSIVE RELAPSE Mindfulness-Based Treatment Approaches, 10.1016/B978-012088519-0/50003-4, (31-50), . Kronmüller K, Saha R, Karr M, Kratz B, Hunt A, Mundt C and Backenstrass M (2006) Psychosocial Factors Associated with Knowledge about Affective Disorders in Patients with Depression, Psychopathology, 10.1159/000091794, 39:3, (105-112), . Conus P, Berk M and McGorry P (2006) Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?, Australian and New Zealand Journal of Psychiatry, 10.1111/j.1440-1614.2006.01775.x, 40:3, (199-207), Online publication date: 1-Mar-2006. Kronmüller K, Kratz B, Karr M, Schenkenbach C, Mundt C and Backenstraß M (2006) Inanspruchnahme eines psychoedukativen Gruppenangebotes für Angehörige von Patienten mit affektiven StörungenTreatment utilisation of a psychoeducational group for relatives of patients with affective disorders, Der Nervenarzt, 10.1007/s00115-005-1894-9, 77:3, (318-326), Online publication date: 1-Mar-2006. Rush A Algorithmusgestützte Behandlung Akute und therapieresistente Depressionen, 10.1007/3-540-28049-9_34, (459-476) (2016) Australian and New Zealand Clinical Practice Guidelines for the Treatment of Bipolar Disorder, Australian & New Zealand Journal of Psychiatry, 10.1080/j.1440-1614.2004.01356.x, 38:5, (280-305), Online publication date: 1-May-2004. Sherbourne C, Schoenbaum M, Wells K and Croghan T (2004) Characteristics, treatment patterns, and outcomes of persistent depression despite treatment in primary care, General Hospital Psychiatry, 10.1016/j.genhosppsych.2003.08.009, 26:2, (106-114), Online publication date: 1-Mar-2004. (2004) Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder, Australian and New Zealand Journal of Psychiatry, 10.1111/j.1440-1614.2004.01356.x, 38:5, (280-305), Online publication date: 1-May-2004. Fava M, Rush A, Trivedi M, Nierenberg A, Thase M, Sackeim H, Quitkin F, Wisniewski S, Lavori P, Rosenbaum J, Kupfer D and for the STAR∗D Investigators Group (2003) Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study, Psychiatric Clinics of North America, 10.1016/S0193-953X(02)00107-7, 26:2, (457-494), Online publication date: 1-Jun-2003. Fagiolini A and Kupfer D (2003) Is treatment-resistant depression a unique subtype of depression?, Biological Psychiatry, 10.1016/S0006-3223(02)01670-0, 53:8, (640-648), Online publication date: 1-Apr-2003. Segal Z, Pearson J and Thase M (2003) Challenges in preventing relapse in major depression, Journal of Affective Disorders, 10.1016/S0165-0327(02)00112-X, 77:2, (97-108), Online publication date: 1-Nov-2003. Harvey B, McEwen B and Stein D (2003) Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression, Biological Psychiatry, 10.1016/S0006-3223(03)00528-6, 54:10, (1105-1117), Online publication date: 1-Nov-2003. Frank E, Rush A, Blehar M, Essock S, Hargreaves W, Hogan M, Jarrett R, Johnson R, Katon W, Lavori P, McNulty J, Niederehe G, Ryan N, Stuart G, Thomas S, Tollefson G and Vitiello B (2002) Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders, Biological Psychiatry, 10.1016/S0006-3223(02)01467-1, 52:6, (631-654), Online publication date: 1-Sep-2002. Conus P, Conus P and Mcgorry P (2016) First-Episode Mania: A Neglected Priority for Early Intervention, Australian & New Zealand Journal of Psychiatry, 10.1046/j.1440-1614.2002.00994.x, 36:2, (158-172), Online publication date: 1-Apr-2002. Hirose S (2008) Restlessness related to SSRI withdrawal, Psychiatry and Clinical Neurosciences, 10.1046/j.1440-1819.2001.00789.x, 55:1, (79-80), Online publication date: 1-Feb-2001. Fischer E, Marder S, Smith G, Owen R, Rubenstein L, Hedrick S and Curran G (2000) Quality Enhancement Research Initiative in Mental Health, Medical Care, 10.1097/00005650-200006001-00008, 38, (I-70-I-81), Online publication date: 1-Jun-2000. Goldman L, Nielsen N and Champion H (1999) Awareness, diagnosis, and treatment of depression, Journal of General Internal Medicine, 10.1046/j.1525-1497.1999.03478.x, 14:9, (569-580), Online publication date: 1-Sep-1999. Smith D (1999) Commentary: The Limits of Biological Psychiatry, Journal of the American Academy of Psychoanalysis, 10.1521/jaap.1.1999.27.4.671, 27:4, (671-680), Online publication date: 1-Dec-1999. Basco M and Thase M (1998) Cognitive-Behavioral Treatment of Bipolar Disorder International Handbook of Cognitive and Behavioural Treatments for Psychological Disorders, 10.1016/B978-008043433-9/50019-5, (521-550), . McFarland B (2016) Automated Pharmacy Databases and Behavioral Health Care Quality Assurance, Evaluation Review, 10.1177/0193841X9702100312, 21:3, (371-378), Online publication date: 1-Jun-1997. Ghaemi S (1997) Insight and Psychiatric Disorders: A Review of the Literature, with a Focus on its Clinical Relevance for Bipolar Disorder, Psychiatric Annals, 10.3928/0048-5713-19971201-07, 27:12, (782-790), Online publication date: 1-Dec-1997. Thase M (1996) THE ROLE OF AXIS II COMORBIDITY IN THE MANAGEMENT OF PATIENTS WITH TREATMENT-RESISTANT DEPRESSION, Psychiatric Clinics of North America, 10.1016/S0193-953X(05)70289-6, 19:2, (287-309), Online publication date: 1-Jun-1996. Schulberg H, Magruder K and deGruy F (1996) Major depression in primary medical care practice, General Hospital Psychiatry, 10.1016/S0163-8343(96)00093-X, 18:6, (395-406), Online publication date: 1-Nov-1996. Gaulin B (2016) The Use of Anticonvulsants in Psychiatry, Journal of Pharmacy Practice, 10.1177/089719009600900206, 9:2, (104-112), Online publication date: 1-Apr-1996. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download